Diamyd Medical AB (publ) (FRA:DMN)

Diamyd Medical AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is September - August.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 23, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Market Capitalization	211	140	144	71	105	237
Market Cap Growth	38.43%	-2.83%	103.88%	-32.46%	-55.71%	-10.78%
Enterprise Value	189	111	130	64	87	217
Last Close Price	1.49	0.99	1.28	0.79	1.32	3.00
PE Ratio	-	-	-	-	-	40.17
PS Ratio	6629.56	11951.90	12595.78	1538.11	2470.47	9533.21
PB Ratio	9.99	5.55	11.22	4.96	5.23	12.74
P/TBV Ratio	9.99	5.55	11.22	4.96	5.23	12.75
EV/Sales Ratio	-	9496.04	11346.68	1396.51	2045.78	8765.65
EV/FCF Ratio	-11.55	-	-	-	-	-
Net Debt / Equity Ratio	-1.01	-0.99	-0.91	-0.75	-0.74	-0.74
Net Debt / EBITDA Ratio	1.28	1.57	0.93	1.15	1.44	1.63
Net Debt / FCF Ratio	1.30	1.54	0.97	1.04	1.25	1.23
Asset Turnover	0.00	0	0.00	0.00	0.00	0.00
Quick Ratio	9.19	10.25	3.41	6.66	7.59	12.37
Current Ratio	9.50	10.64	3.98	7.09	8.10	14.29
Return on Equity (ROE)	-94.11%	-79.72%	-96.32%	-60.49%	-51.29%	45.88%
Return on Assets (ROA)	-45.01%	-40.21%	-43.54%	-32.74%	-32.80%	-36.95%
Return on Capital Employed (ROCE)	-68.40%	-56.40%	-83.20%	-62.30%	-53.40%	-45.30%
Earnings Yield	-7.89%	-10.93%	-9.27%	-13.82%	-9.23%	2.49%
FCF Yield	-7.76%	-11.57%	-8.38%	-14.57%	-11.40%	-4.71%
Buyback Yield / Dilution	-23.27%	-18.81%	-20.98%	-2.29%	-9.65%	-0.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.